A single centre proof of concept study to assess whether Vitamin C improves the efficacy of Methenamine Hippurate (Hiprex®) in the prophylaxis of recurrent urinary tract infections (rUTIs) in women

开始日期2026-01-01

申办/合作机构

University Hospitals of North Midlands NHS Trust

NCT07202949

/ Not yet recruiting临床2期IIT

EAT-UP - Extended Antibiotic Treatment in Chronic UTI Patients; a Phase II Safety and Efficacy Trial

Chronic Urinary Tract Infection (UTI) is a type of UTI where symptoms are constant and occur every day, unlike recurrent UTIs, which come and go with symptom-free breaks in between. Current treatment for chronic UTI within the NHS is based on recommended guidelines for recurrent UTI. The standard approach typically includes one of the following treatments:
* Long-term, prophylactic (low) dose daily antibiotic (where medication is used at low doses to try to prevent symptoms reoccurring).
* Long-term use of a urinary antiseptic (which helps keep your urine bacteria free), called methenamine hippurate.
These often do not work for people with chronic UTI, and symptoms can persist. Moreover, standard urine tests may fail to detect infections, making diagnosis and treatment more challenging.
The EAT-UP trial will investigate whether longer courses of treatment (higher) dose antibiotics combined with methenamine hippurate (a urinary antiseptic) are a more effective treatment at reducing levels of infection and symptoms than standard of care treatments (as described above).

开始日期2025-12-01

申办/合作机构

University College London

CTR20252444

/ CompletedN/A

马尿酸乌洛托品片在中国健康受试者中单次空腹/餐后口服给药、随机、开放、单中心、两制剂、两序列、两周期、交叉生物等效性试验

评价中国健康成人受试者空腹/餐后状态下口服成都恒瑞制药有限公司生产的马尿酸乌洛托品片（1g，受试制剂）与Meda Pharma GmbH & Co. KG生产的参比制剂马尿酸乌洛托品片（Hiprex®，规格：1g）是否具有生物等效性。

开始日期2025-06-09

申办/合作机构

成都恒瑞制药有限公司

100 项与马尿酸乌洛托品相关的临床结果

登录后查看更多信息

100 项与马尿酸乌洛托品相关的转化医学

登录后查看更多信息

100 项与马尿酸乌洛托品相关的专利（医药）

登录后查看更多信息

465

项与马尿酸乌洛托品相关的文献（医药）

2026-01-01·JOURNAL OF COLLOID AND INTERFACE SCIENCE

A hybrid supercapacitor containing NiO microflowers as cathode material with enhanced energy storage performance

Article

作者: Chen, Huiyu ; Chen, Ping ; Han, Xingcheng ; Wang, Gaojuan ; Li, Zuoqi ; Xu, Chunju ; Tu, Chuanxian

The NiO microflowers electrode material was synthesized through a simple and low-cost hydrothermal method using hexamethylenetetramine (HMTA) to provide hydroxide ions for the formation of corresponding precursors. On this basis, the effect of HMTA dosage on the morphology and electrochemical performance of nickel oxide was investigated. Two kinds of NiO powdered materials with distinct morphologies were successfully prepared. The NiO microflowers demonstrated a larger specific surface area (SSA, 142.43 m² g^-1) and a higher specific capacity (C_s) of 661.4 C g^-1. While the NiO microspheres possessed smaller SSA of 104.3 m² g^-1 and inferior C_s of 594.6 C g^-1. The NiO materials were employed as the cathode and activated carbon (AC) as the anode to assemble hybrid supercapacitor (HSC), which was expressed as NiO microflowers//AC and NiO microspheres//AC, respectively. Compared with the 53.5 W h kg^-1 energy density (ED) of NiO microspheres//AC, the NiO microflowers//AC achieved a higher ED of 55.4 W h kg^-1. Both HSCs showed over 90 % capacity retention after 4000 cycles at 10 A g^-1, indicating that the two HSCs exhibited excellent cyclic lifespan. It suggests that the NiO electrode materials in this study show promising potential for electrochemical energy storage application. The current synthesis approach demonstrates notable advantages including simplicity, time and energy saving, and may be straightforwardly employed to prepared other electrode materials with controlled morphologies and superior electrochemical performance.

2025-12-31·RENAL FAILURE

Histone methylation of kidney disease: fact or fantasy?

Review

作者: Hu, Lan ; Hu, Qin ; Zhang, Xuelian ; Li, Xu ; Jin, Hua

Histone methylation (HMT), the enzymatic addition of methyl groups to specific histone residues by histone methyltransferases, constitutes a key regulatory mechanism in gene expression and post-translational modulation. Although studies have explored HMT's role in oncogenesis and other organ-specific disorders, HMT is now implicated in the pathogenesis of kidney diseases. A broad spectrum of experimental models, including both in vivo and in vitro systems, has demonstrated the involvement of HMT alterations in diverse renal pathologies such as acute kidney injury, renal fibrosis, diabetic nephropathy, lupus nephritis, polycystic kidney disease, kidney stones, renal cell carcinoma, and immunoglobulin A nephropathy. Targeted modulation of HMT has been associated with attenuated disease progression across these conditions. This review synthesizes current insights into HMT's mechanistic roles in renal pathology and delineates its therapeutic potential as a strategic intervention in kidney disease management.

2025-12-01·FOOD CHEMISTRY

Effect of sequential hydrothermal treatments on the physicochemical properties and in vitro digestibility of bitter vetch (vicia ervilia) starch

Article

作者: Hedayati, Sara ; Dokouhaki, Mina ; Niakousari, Mehrdad ; Mejares, Carolyn T ; Tarahi, Mohammad

This study evaluated the effects of single (heat-moisture treatment (HMT, 120 °C/24 h, 30 % moisture) and annealing (ANN, 50 °C/24 h, 70 % moisture)) and sequential (HMT-ANN and ANN-HMT) hydrothermal modifications on the physicochemical and digestibility properties of bitter vetch starch (BVS). The most significant reduction in peak and setback viscosities was observed in HMT sample, decreasing from 3278 ± 33 cP to 1467 ± 47 cP and from 3199 ± 79 cP to 406 ± 10 cP, respectively, compared to the native starch. DSC experiment confirmed elevated gelatinization temperatures, with onset (T_o) increasing from 59.54 ± 0.08 °C (native) to 69.35 ± 0.01 °C (HMT-ANN), accompanied by higher enthalpy (ΔH) values, from 7.12 ± 0.05 J/g to 11.40 ± 0.13 J/g. XRD and FTIR analyses indicated increased crystallinity (from 33.51 to 41.78 %) and short-range molecular order (1047/1022 ratio from 0.9812 to 0.9885), whereas SEM images of starch gels revealed primarily morphological changes. Gel hardness was notably reduced following HMT (222.1 ± 9.1 g) and HMT-ANN (253.6 ± 9.3 g), suggesting that dense crystallinity and limited chain mobility hindered the formation of firm gels. Importantly, in vitro digestibility assays showed that HMT and HMT-ANN treatments increased resistant and slowly digestible starch fractions by approximately 1.5- and 4-fold, respectively, indicating potential for low-glycemic food applications. These findings highlight the promising role of hydrothermal treatments in tailoring the functionality of BVS for clean-label, health-promoting food systems.

项与马尿酸乌洛托品相关的新闻（医药）

2025-10-26

·道道之道

【本周医刊】2025年第43周医学期刊更新

2025年第43周（2025.10.19-2025.10.25）重要医学期刊论著更新如下： 1.综合期刊 LANCET 题目：Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial 翻译：伊布替尼联合利妥昔单抗对比免疫化疗治疗初治套细胞淋巴瘤患者（ENRICH研究）：一项随机、开放标签、2/3期优效性试验题目：Prognostic accuracy of clinical markers of postpartum bleeding in predicting maternal mortality or severe morbidity: a WHO individual participant data meta-analysis 翻译：产后出血临床标志物预测孕产妇死亡或严重并发症的预后准确性：一项世界卫生组织（WHO）个体参与者数据荟萃分析题目：Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trial 翻译：每日一次舒噻美治疗阻塞性睡眠呼吸暂停（FLOW研究）：一项多中心、随机、双盲、安慰剂对照、剂量探索2 期试验题目：Assessment of malnutrition in preschool-aged children by mid-upper arm circumference in the Gaza Strip (January, 2024–August, 2025): a longitudinal, cross-sectional, surveillance study 翻译：加沙地带通过上臂中围评估学龄前儿童营养不良状况（2024年1 月—2025年8 月）：一项纵向横断面监测研究 NEW ENGLAND JOURNAL OF MEDICINE 题目：Hypertonic Saline or Carbocisteine in Bronchiectasis 翻译：支气管扩张症中的高渗盐水或羧甲司坦题目：Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation 翻译：阿司匹林在接受口服抗凝治疗的慢性冠状动脉综合征患者中的作用题目：Common Diseases in Clinical Cohorts — Not Always What They Seem 翻译：临床队列中的常见疾病——并非总是看起来那样题目：Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis 翻译：索他西普用于诊断后第一年内的肺动脉高压题目：Association of 2024–2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans 翻译：2024-2025 年新冠疫苗与美国退伍军人新冠病毒感染结局的关联 BMJ-BRITISH MEDICAL JOURNAL 题目：Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes 翻译：受孕后前 1000 天糖配给暴露与长期心血管结局题目：Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia 翻译：抗 CD38 单克隆抗体CM313 用于原发性免疫性血小板减少症 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 题目：Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial 翻译：儿童心脏移植后使用依维莫司和低剂量他克莫司的随机临床试验题目：Remote Screening for Asymptomatic Atrial Fibrillation: The AMALFI Randomized Clinical Trial 翻译：无症状性心房颤动的远程筛查：AMALFI 随机临床试验 NATURE MEDICINE 题目：Cardiotropic AAV gene therapy for heart failure: a phase 1 trial 翻译：心力衰竭的亲心肌腺相关病毒（AAV）基因疗法：一项1 期试验题目：Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial 翻译：SARS-CoV-2 DNA 编码的单克隆抗体在健康成年人中的安全性和药代动力学：一项1 期试验题目：Plasma proteome adaptations during feminizing gender-affirming hormone therapy 翻译：女性化性别确认激素治疗期间的血浆蛋白质组适应性变化题目：Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis 翻译：在多发性硬化症中，髓鞘损伤先于轴突损伤和症状发作题目：Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial 翻译：循环肿瘤 DNA 指导的局部晚期结肠癌辅助治疗：随机2/3 期DYNAMIC-III 试验题目：YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial 翻译：YAP/TEAD 抑制剂VT3989 用于实体瘤：一项1/2 期试验 LANCET DIGITAL HEALTH（本周无更新） NPJ DIGITAL MEDICINE 题目：Evaluating human-in-the-loop strategies for artificial intelligence-enabled translation of patient discharge instructions: a multidisciplinary analysis 翻译：评估人工智能辅助的患者出院指导翻译中人工介入策略：一项多学科分析题目：Active remote monitoring of long-term conditions with mobile devices: a systematic review of cost-effectiveness analyses 翻译：使用移动设备对长期病症进行主动远程监测：成本效益分析的系统综述题目：Real-time detection of respiratory circuit events in mechanical ventilation using deep learning 翻译：基于深度学习的机械通气中呼吸回路事件的实时检测题目：HONeYBEE: enabling scalable multimodal AI in oncology through foundation model-driven embeddings 翻译：HONeYBEE：通过基础模型驱动的嵌入在肿瘤学中实现可扩展的多模态人工智能题目：Location and amount of joint involvement differentiates rheumatoid arthritis into different clinical subsets 翻译：关节受累的部位和程度将类风湿关节炎分为不同的临床亚组题目：Streamlined machine learning model for early sepsis risk prediction in burn patients 翻译：用于烧伤患者早期败血症风险预测的简化机器学习模型题目：A deep learning based automatic report generator for retinal optical coherence tomography images 翻译：基于深度学习的视网膜光学相干断层扫描图像自动报告生成器 2.肿瘤学 CA-A CANCER JOURNAL FOR CLINICIANS（本周无更新） ANNALS OF ONCOLOGY 题目：Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase 3 trial 翻译：曲妥珠单抗德鲁替康单药或序贯紫杉醇、曲妥珠单抗和帕妥珠单抗用于高危HER2 阳性早期乳腺癌（DESTINY-Breast11）：一项随机、开放标签、多中心的3 期试验题目：Improved survival and rising incidence: insights from the largest retrospective study on leptomeningeal metastases in patients with NSCLC 翻译：生存率提高与发病率上升：来自非小细胞肺癌脑膜转移最大规模回顾性研究的见解题目：Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy 翻译：在 SERENA-6 试验中，卡米司琼联合CDK4/6 抑制剂治疗一线内分泌治疗期间出现ESR1 突变的晚期乳腺癌患者的患者报告结局题目：The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study 翻译：非小细胞肺癌脑膜转移的演变格局：一项国际性、当代、多中心队列研究题目：Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 Phase III study 翻译：Capivasertib 联合阿比特龙用于PTEN 缺陷型转移性激素敏感性前列腺癌：CAPItello-281 3 期研究 JOURNAL OF CLINICAL ONCOLOGY（本周无更新） LANCET ONCOLOGY（本周无更新） NATURE CANCER 题目：Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapy 翻译：用膜结合型 SLP-76 改造T 细胞可克服CAR-T 细胞疗法对低抗原的耐药性题目：MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis 翻译：表达 MEF2D 的癌前细胞重编程组织驻留巨噬细胞以支持肝脏肿瘤发生 JAMA ONCOLOGY（本周无更新） CANCER RESEARCH（本周无更新） CLINICAL CANCER RESEARCH（本周无更新） JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE（本周无更新） 3.内分泌学与代谢 LANCET DIABETES & ENDOCRINOLOGY（本周无更新） 4.呼吸病学 LANCET RESPIRATORY MEDICINE（本周无更新） 5.心血管病学 EUROPEAN HEART JOURNAL 题目：Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial 翻译：阿凡卡坦治疗症状轻微的梗阻性肥厚型心肌病患者的疗效：SEQUOIA-HCM试验结果题目：Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool 翻译：从单个超声心动图视频片段检测心脏淀粉样变性：一种新型的基于人工智能的筛查工具题目：Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model 翻译：恩格列净在肥厚型心肌病小鼠模型中提高代谢效率并改善左心室肥厚 CIRCULATION 题目：Ivabradine in Patients Undergoing Noncardiac Surgery: A Randomized Controlled Trial 翻译：伊伐布雷定在非心脏手术患者中的应用：一项随机对照试验题目：Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial 翻译：沙库巴曲缬沙坦与辅助乳腺癌治疗期间心脏功能障碍的预防：PRADA II 随机临床试验题目：PYGM Protects Against Myocardial Infarction by Enhancing Glycogenolysis and Facilitating Autophagic Flux 翻译：PYGM 通过增强糖原分解和促进自噬流来预防心肌梗死 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 题目：Effect of Intensive Blood Pressure Lowering Treatment on Retinal Microvasculature: Secondary Analysis From ESPRIT 翻译：强化降压治疗对视网膜微血管的影响：ESPRIT研究的二次分析题目：Modest Effects of Intensive Blood Pressure–Lowering on Quality of Life in Patients at High Cardiovascular Risk: The ESPRIT Trial 翻译：强化降压对高心血管风险患者生活质量的适度影响：ESPRIT试验题目：Effect of Intensive Blood Pressure Control on Stroke: A Prespecified Secondary Analysis of the ESPRIT Trial 翻译：强化血压控制对中风的影响：ESPRIT 试验的预先指定二次分析题目：Intensive Blood Pressure Control in Older Patients With Hypertension: 6-Year Results of the STEP Trial 翻译：老年高血压患者的强化血压控制：STEP 试验的6 年结果题目：Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT 翻译：使用 PREVENT 方程比较SPRINT 研究中强化与标准收缩压控制用于一级预防的效果 6.传染病学 LANCET INFECTIOUS DISEASES 题目：Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study 翻译：奥洛非芬用于治疗几乎无治疗选择或无治疗选择的侵袭性真菌病患者：一项单臂、开放标签的2b 期研究题目：Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study 翻译：智利全国呼吸道合胞病毒（RSV）免疫策略首个季节中尼塞韦单抗的有效性及影响（NIRSE-CL研究）：一项回顾性观察研究题目：Incidence of health-care-associated infections in long-term care facilities in nine European countries: a 12-month, prospective, longitudinal cohort study 翻译：欧洲 9 个国家长期护理机构中医院相关性感染的发生率：一项为期12 个月的前瞻性纵向队列研究题目：Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial 翻译：舒他唑利联合贝达喹啉、德拉马尼与莫西沙星治疗肺结核（PanACEA-SUDOCU-01研究）：一项前瞻性、开放标签、随机的2b 期剂量探索试验题目：Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial 翻译：地帕唑利联合贝达喹啉、德拉马尼与莫西沙星治疗肺结核（PanACEA-DECODE-01研究）：一项前瞻性、随机、开放标签的2b 期剂量探索试验题目：Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial 翻译：新一代 mRNA-1283 新冠疫苗与mRNA-1273 疫苗的有效性、免疫原性及安全性对比（NextCOVE研究）：一项3 期、随机、观察者设盲、活性对照试验结果题目：Extended nirmatrelvir–ritonavir treatment durations for immunocompromised patients with COVID-19 (EPIC-IC): a placebo-controlled, randomised, double-blind, phase 2 trial 翻译：延长奈玛特韦 - 利托那韦治疗免疫功能低下新冠患者的疗程（EPIC-IC研究）：一项安慰剂对照、随机、双盲的2 期试验题目：Efficacy and safety of ascending doses of emodepside in comparison with ivermectin in adults infected with Strongyloides stercoralis in Laos: a phase 2a, dose-ranging, randomised, parallel-group, placebo-controlled, single-blind clinical trial 翻译：老挝地区感染粪类圆线虫的成人中，递增剂量的依莫帕米与伊维菌素的有效性及安全性对比：一项2a 期、剂量范围探索、随机、平行组、安慰剂对照、单盲临床试验 CLINICAL MICROBIOLOGY AND INFECTION 题目：Survival and quality-of-life in mucormycosis: a multicentric ambispective cohort study 翻译：毛霉菌病患者的生存率与生活质量：一项多中心双向性队列研究题目：Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses 翻译：人类免疫缺陷病毒（HIV）感染者接种多剂新冠疫苗加强针后的体液与细胞免疫应答题目：Characterization of post-acute multi-organ sequelae following dengue infection 翻译：登革热感染后急性后期多器官后遗症的特征分析题目：Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women—a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU) 翻译：马尿酸乌洛托品用于老年女性复发性尿路感染的预防——一项三盲、随机、安慰剂对照的IV 期试验（ImpresU研究）题目：Clinical performance of a genotyping assay based on a hybrid capture technique in cervical cancer screening in China: a prospective population-based multicentre cohort study 翻译：基于杂交捕获技术的基因分型检测在中国宫颈癌筛查中的临床性能：一项基于人群的前瞻性多中心队列研究题目：Multicentre evaluation of a EUCAST-based agar-screening method for terbinafine and itraconazole susceptibility of Trichophyton spp 翻译：基于欧洲抗菌药物敏感性试验委员会（EUCAST）标准的琼脂筛查法用于毛癣菌属对特比萘芬和伊曲康唑敏感性检测的多中心评价题目：Enterobacteralesgut colonization and late-onset sepsis in neonates: a multicentre prospective study across 18 neonatal intensive care units in six countries 翻译：新生儿肠道肠杆菌目细菌定植与晚发性败血症：一项涵盖6 国18 个新生儿重症监护室的多中心前瞻性研究题目：Effectiveness of COVID-19 vaccination among dialysis and kidney transplant patients compared with matched controls—a nationwide cohort study 翻译：透析与肾移植患者新冠疫苗接种的有效性：一项与匹配对照人群对比的全国性队列研究题目：Screening and targeted prophylaxis for Clostridioides difficile infection 翻译：艰难梭菌感染的筛查与靶向预防 7.胃肠肝病学 LANCET GASTROENTEROLOGY & HEPATOLOGY（本周无更新） JOURNAL OF HEPATOLOGY（本周无更新） GASTROENTEROLOGY 题目：Barrett’s Oesophagus Surveillance Versus Endoscopy at Need Study (BOSS): A Randomized Controlled Trial 翻译：巴雷特食管监测与按需内镜检查研究（BOSS）：一项随机对照试验题目：Cost-Effectiveness of Regular Surveillance Versus Endoscopy at Need for Patients With Barrett’s Esophagus: Economic Evaluation Alongside the Barrett’s Oesophagus Surveillance Study (BOSS) Randomized Controlled Trial 翻译：巴雷特食管患者定期监测与按需内镜检查的成本效益：基于巴雷特食管监测研究（BOSS）随机对照试验的经济学评价题目：Blood-Based T-Cell Diagnosis of Celiac Disease 翻译：基于血液的 T 细胞检测诊断乳糜泻题目：Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis 翻译：胰高血糖素样肽 - 1 受体激动剂与胃肠道不良事件：一项系统评价与荟萃分析题目：An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease 翻译：炎症性肠病临床试验中糖皮质激素合理使用的国际共识 GUT 题目：Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort 翻译：高危队列中与丙型肝炎病毒再感染保护相关的抗体谱特征题目：SIRT6 promotes intrahepatic cholangiocarcinoma development by reprogramming glutamine metabolism via enhanced GLUL 翻译：SIRT6 通过增强GLUL 重编程谷氨酰胺代谢，从而促进肝内胆管癌发生发展题目：First genome-wide association study reveals immune-mediated aetiopathology in idiopathic achalasia 翻译：首项全基因组关联研究揭示特发性贲门失弛缓症的免疫介导发病机制题目：iPSC-induced multilineage liver organoids, small intestinal organoids and brain organoids sustain pangenotype hepatitis E virus propagation 翻译：诱导多能干细胞（iPSC）构建的多谱系肝类器官、小肠类器官及脑类器官可支持全基因型戊型肝炎病毒增殖题目：PDE5A+cancer-associated fibroblasts enhance immune suppression in gastric cancer 翻译：表达 PDE5A 的癌相关成纤维细胞增强胃癌中的免疫抑制 HEPATOLOGY（本周无更新） CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 题目：Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension Study 翻译：布地奈德口崩片治疗嗜酸性食管炎长达3 年的有效性与安全性：一项开放标签扩展研究题目：Long-term Safety and Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis: A 4-Year, Phase 3, Open-Label Study 翻译：布地奈德口服混悬液治疗嗜酸性食管炎的长期安全性与有效性：一项为期4 年的3 期开放标签研究题目：Endoscopic Ultrasound–Guided Portosystemic Pressure Gradient Correlates With Clinical Parameters and Liver Histology 翻译：内镜超声引导下门体静脉压力梯度与临床指标及肝脏组织学的相关性题目：Effectiveness of Six International Guidelines Using Fibrosis-4 and FibroScan for Risk Stratification of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes 翻译：采用 FIB-4 指数与FibroScan（瞬时弹性成像）的6 项国际指南对2 型糖尿病患者中代谢功能障碍相关脂肪性肝病风险分层的有效性题目：Gender-Equity Model for Liver Allocation Using Artificial Intelligence (GEMA-AI) for Waiting List Liver Transplant Prioritization 翻译：基于人工智能的性别公平肝分配模型（GEMA-AI）用于肝移植等待名单优先级排序题目：Colorectal Cancer Incidence in Steatotic Liver Disease (MASLD, MetALD, and ALD) 翻译：脂肪性肝病（代谢相关脂肪性肝病、代谢相关脂肪性肝炎、酒精性肝病）中的结直肠癌发病率题目：Association of Alcohol and Incremental Cardiometabolic Risk Factors With Liver Disease: A National Cross-sectional Study 翻译：酒精与累积性 cardiometabolic（心脏代谢）危险因素与肝病的关联：一项全国性横断面研究题目：Early Occurrence of Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt Insertion is Linked to Impaired Survival: A Multicenter Cohort Study 翻译：经颈静脉肝内门体分流术（TIPS）后早期发生肝性脑病与生存期缩短相关：一项多中心队列研究题目：Testosterone Replacement Reduces Morbidity and Mortality for Most Patients With Cirrhosis 翻译：睾酮替代治疗降低大多数肝硬化患者的发病率与死亡率题目：Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome 翻译：肝硬化患者中的门诊急性肾损伤常见且危害大题目：Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease 翻译：异基因造血干细胞移植治疗单基因遗传性炎症性肠病的结局题目：Biologic Switch Timing and Risk of Infection in Patients With Ulcerative Colitis/Crohn’s Disease: A Retrospective Study 翻译：溃疡性结肠炎 / 克罗恩病患者中生物制剂转换时机与感染风险：一项回顾性研究题目：Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy 翻译：接受托法替尼治疗的急性重症溃疡性结肠炎患者行结肠切除术后的结局题目：Cholecystectomy Is a Risk Factor for Microscopic Colitis: A Nationwide Population-based Matched Case Control Study 翻译：胆囊切除术是显微镜下结肠炎的危险因素：一项全国性基于人群的匹配病例对照研究题目：Real-World Effectiveness and Safety of Upadacitinib in Crohn’s Disease: A Multicenter Study 翻译：乌帕替尼治疗克罗恩病的真实世界有效性与安全性：一项多中心研究题目：Risks of 75 Major Congenital Malformations After In Utero Exposure to Thiopurines and Anti-TNF for Maternal Inflammatory Bowel Disease 翻译：母亲患炎症性肠病时，胎儿宫内暴露于硫嘌呤类药物与抗TNF 药物后75 种主要先天性畸形的风险题目：Effect, Tolerability, and Safety of Exclusive Palatable Elemental Diet in Patients With Intestinal Microbial Overgrowth 翻译：专用适口性要素饮食治疗肠道微生物过度生长患者的疗效、耐受性与安全性题目：Simplifying Diagnosis of Bile Acid Diarrhea With Clinical and Biochemical Measurements on Blood and Single Stool Sample 翻译：通过血液与单次粪便样本的临床及生化检测简化胆汁酸性腹泻的诊断题目：Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer: Universal Germline vs Sequential Screening 翻译：结直肠癌中林奇综合征筛查的成本效益：全面生殖细胞筛查与序贯筛查对比 8.公共卫生和流行病学 LANCET PUBLIC HEALTH（本周无更新） LANCET PLANETARY HEALTH（本周无更新） LANCET GLOBAL HEALTH（本周无更新） 9.微生物学 FUNGAL DIVERSITY（本周无更新） LANCET MICROBE（本周无更新） NATURE MICROBIOLOGY 题目：Bacterial TIR-based immune systems sense phage capsids to initiate defense 翻译：细菌中基于 TIR 结构域的免疫系统通过感知噬菌体衣壳启动防御题目：Engineered Metarhizium fungi produce longifolene to attract and kill mosquitoes 翻译：工程改造的绿僵菌可产生长叶烯以吸引并杀灭蚊子题目：A widespread hydrogenase supports fermentative growth of gut bacteria in healthy people 翻译：一种广泛存在的氢化酶可支持健康人群肠道细菌的发酵生长题目：Long-read metagenomics for strain tracking after faecal microbiota transplant 翻译：长读长宏基因组学用于粪便微生物群移植后的菌株追踪题目：Activity-targeted metaproteomics uncovers rare syntrophic bacteria central to anaerobic community metabolism 翻译：活性靶向宏蛋白质组学揭示对厌氧群落代谢至关重要的稀有互营细菌 MICROBIOME 题目：Natural sex reversal imparts permanent compositional changes to the swamp eel gonadal microbiome 翻译：自然性逆转对黄鳝性腺微生物组的组成产生永久性改变题目：One Health, One Microbiome 翻译：同一健康，同一微生物组（注：“同一健康”（One Health 题目：Altered ruminal microbiome tryptophan metabolism and their derived 3-indoleacetic acid inhibit ruminal inflammation in subacute ruminal acidosis goats 翻译：亚急性瘤胃酸中毒山羊瘤胃微生物组色氨酸代谢改变及其产生的3 - 吲哚乙酸可抑制瘤胃炎症题目：Reovirus infection results in rice rhizosphere microbial community reassembly through metabolite-mediated recruitment and exclusion 翻译：呼肠孤病毒感染通过代谢物介导的招募与排斥作用，导致水稻根际微生物群落重组题目：Host miRNAs regulate Escherichia coli O157 mucosal colonization through host-mucosa-attached microbiota interactions in calves 翻译：犊牛宿主微小 RNA（miRNA）通过宿主- 黏膜附着微生物群的相互作用，调控大肠杆菌O157 的黏膜定植题目：Improving fecal transplantation precision for enhanced maturation of intestinal function in germ-free mice through microencapsulation and probiotic intervention 翻译：通过微囊包埋与益生菌干预提高粪便移植精度，促进无菌小鼠肠道功能成熟题目：Megasphaeracontributes to lactate-driven valerate production in the human gut 翻译：巨球型菌属（Megasphaera）参与人肠道中由乳酸驱动的戊酸生成题目：Silica nanoparticles suppress fungal pathogenic allies to alleviate Astragalus root rot 翻译：二氧化硅纳米颗粒通过抑制真菌病原的协同菌，缓解黄芪根腐病 10.内科学 JAMA INTERNAL MEDICINE（本周无更新） ANNALS OF INTERNAL MEDICINE 题目：Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood 翻译：儿童时期的铝吸附疫苗与慢性疾病题目：Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes 翻译：能量限制的地中海饮食及体育活动与自由进食地中海饮食在预防2 型糖尿病方面的比较题目：Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening 翻译：个性化风险信息对结直肠癌筛查接受度的影响题目：Long-Term Routine Laboratory Toxicity Monitoring of Immunomodulatory Drugs in Rheumatoid Arthritis 翻译：类风湿关节炎中免疫调节药物的长期常规实验室毒性监测题目：Effect of Systolic Blood Pressure Measurement Error on the Cost-Effectiveness of Intensive Blood Pressure Targets 翻译：收缩压测量误差对强化血压目标成本效益的影响题目：Geographic Variation in the Utilization of Cancer Care From Subspecialized Medical Oncologists in the United States, 2008 to 2020 翻译：2008 年至2020 年美国亚专科肿瘤内科医生提供的癌症护理利用情况的地域差 11.牙科与口腔外科 JOURNAL OF CLINICAL PERIODONTOLOGY（本周无更新）

临床结果疫苗临床2期临床1期

2025-03-12

·ETPharma

Zydus Methenamine Hippurate tablet gets FDA final nod

New Delhi: Zydus Lifesciences announced its final approval from the US Food and Drug Administration to manufacture and market Methenamine Hippurate tablet in the country’s drug market. The drug is indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. Methenamine Hippurate tablets is a generic drug and the company will manufacture the drugs at its Ahmedabad facility . As per IQVIA analysis in the last twelve month period ending January 2025, Methenamine Hippurate tablets had reported net sales of $32.6 million in the United States. Post this approval, the Indian drug maker now has 419 approvals and has filed 483 ANDAs since the commencement of the filing process in FY 2003-04. By Online Bureau ,

上市批准

2024-08-23

·ETPharma

Govt bans 156 medicines including antibiotics, painkillers, multivitamins: Here is the full list

New Delhi: In a significant move aimed at safeguarding public health, the Indian government has banned 156 fixed-dose combination (FDC) drugs, including a variety of antibiotics, painkillers, multivitamins, and medications for treating fever and hypertension. This decision marks the largest crackdown on FDCs since 2016, when 344 such drugs were prohibited. The Union Ministry of Health and Family Welfare issued a gazette notification on Thursday, officially prohibiting the manufacture, sale, and distribution of the banned FDCs. The ban was based on the recommendations of an expert panel that reviewed a total of 324 FDCs. Impact on Pharmaceutical Industry The banned FDCs include popular combinations such as mefenamic acid and paracetamol injections, commonly used for pain relief and fever, and omeprazole magnesium with dicyclomine HCl, used to treat abdominal pain. The ban is expected to impact major pharmaceutical companies, including Sun Pharmaceuticals, Cipla, Dr. Reddy's Laboratories, Torrent Pharmaceuticals, and Alkem Laboratories. Fixed Dose Combinations Drug Banned List Here is a table listing all 156 banned Fixed Dose Combinations (FDCs) SN Fixed Dose Combination (FDC) 1 Amylase + Protease + Glucoamylase + Pectinase + Alpha Galactosidase + Lactase + Beta-Gluconase + Cellulase + Lipase + Bromelain + Xylanase + Hemicellulase + Malt diastase + Invertase + Papain 2 Antimony Potassium Tartrate + Dried Ferrous Sulphate 3 Benfotiamine + Silymarin + L-Ornithine L-aspartate + Sodium Selenite + Folic acid + Pyridoxine hydrochloride 4 Bismuth Ammonium Citrate + Papain 5 Cyproheptadine HCl + Thiamine HCl + Riboflavine + Pyridoxine HCl + Niacinamide 6 Cyproheptadine Hydrochloride + Tricholine Citrate + Thiamine Hydrochloride + Riboflavine + Pyridoxine Hydrochloride 7 Rabeprazole Sodium (As enteric coated tablet) + Clidinium Bromide + Dicyclomine HCl + Chlordiazepoxide 8 Fungal Diastase + Papain + Nux vomica Tincture + Cardamom Tincture + Casein Hydrolysed + Alcohol 9 Mefenamic Acid + Paracetamol Injection 10 Omeprazole Magnesium + Dicyclomine HCl 11 S-adenosyl methionine + Metadoxine + Ursodeoxycholicacid BP + L-Methylfolate Calcium eq. to L- Methylfolate + Choline bitartratee + Silymarin + L-ornithine Laspartate + Inositol + Taurine 12 Silymarin + Thiamine Mononitrate + Riboflavin + Pyridoxine HCl + Niacinamide + Calcium pantothenate + Vitamin B12 13 Silymarin + Pyridoxine HCl + Cyanocobalamin + Niacinamide + Folic Acid 14 Silymarin + Vitamin B6 + Vitamin B12 + Niacinamide + Folic acid + Tricholine Citrate 15 Sodium Citrate + Citric Acid Monohydrate Flavored with Cardamom Oil, Caraway Oil, Cinnamon Oil, Clove Oil, Ginger Oil + Alcohol 16 Sucralfate + Acelofenac 17 Sucralfate + Domperidone + Dimethicone 18 Sucralfate + Domperidone 19 Tincture Ipecacuanha + Tincture Urgenia + Camphorated Opium Tincture + Aromatic Spirit of Ammonia + Chloroform + Alcohol 20 Ursodeoxycholic Acid + Metformin HCl 21 Weak Ginger tincture + Aromatic Spirit of Ammonia + Peppermint Spirit + Chloroform + Sodium Bicarbonate + Compound Cardamom + Alcohol 22 Sucralfate + Pantoprazole Sodium + Zinc Gluconate + Light Magnesium Carbonate 23 Aloe + Vitamin E Soap 24 Povidone Iodine+ Metronidazole + Aloe 25 Azelaic acid + Tea Tree Oil + Salicylic acid + Allantoin + Zinc oxide + Aloe vera + Jojoba oil + Vitamin E + Soap noodles 26 Azithromycin + Adapalene 27 Calamine + Aloes + Allantoin 28 Calamine + Diphenhydramine Hydrochloride + Aloe + Glycerine + Camphor 29 Chlorphenesin + Zinc oxide + Starch 30 Clindamycin Phosphate + Zinc acetate 31 Gamma Benzene Hexachloride + Benzocaine 32 Glucosamine hydrochloride + Diacerein + Menthol + Camphor + Capsaicin 33 Hydroxyquinone 2.0%w/w + Octyl Methoxycinnamate 5.0% w/w + Oxybenzone 30 % w/w 34 Ketoconazole +Zinc Pyrithione +D-Panthenol +Tea Tree Oil +Aloes 35 Ketoconazole +Aloe vera+ Vitamin A Acetate 36 Ketoconazole +Aloes + ZPTO 37 Kojic Acid +Arbutin +Octinoxate +Vitamin E + Mulberry 38 Lornoxicam +capsaicin +menthol+ camphor 39 Lornoxicam + Thiocolchicoside +Oleum Lini +Menthol + Methyl salicylate 40 Menthol + Aloe vera Topical Spray 41 Menthol +Lignocaine HCl +Aloe vera gel +Clotrimazole +Diphenhydramine 42 Miconazole nitrate + Gentamicin + Fluocinolone Acetonide +Zinc Sulphate 43 Miconazole +Tinidazole 44 Minoxidil +Aminexil+ Alcohol 45 Minoxidil +Azelaic acid + saw palmetto 46 Minoxidil +Aminexil 47 Pine Bark extract+ Kojic acid +Sodium Ascorbyl Phosphate 48 Povidone Iodine +Tinidazole +Zinc sulphate 49 Povidone Iodine + Ornidazole + Dexpanthenol 50 Salicyclic acid +Aloe vera+ Allantoin +D-Panthenol 51 Silver sulphadiazine +Chlorhexidine Gluconate solution +Allantoin + Aloe vera gel +Vitamin E acetate 52 Sodium salicylate + Zinc gluconate + Pyridoxine HCl 53 Tetracycline + Colistin Sulphate 54 Clomiphene +Ubidecarenone 55 Combikit of Clomiphene Citrate + Estradiol Valerate 56 Flavoxate HCl +Ofloxacin 57 Clomiphene Citrate +N-Acetylcysteine 58 Primerose Oil +Cod liver oil 59 Sildenafil Citrate +Papaverine +L-Arginine 60 Tranexamic acid +Mefenamic acid + Vitamin K1 61 Divalproex Sodium +Oxcarbazepine 62 Divalproex Sodium + Levetiracitam 63 Ergotamine tartrate +Caffeine + Paracetamol +Prochlorperazine maleate 64 Piracetam + Ginkgo biloba extracts + Vinpocetin 65 Ginkgo biloba + methylcobalamin 66 Ginkgo biloba + methylcobalamin + Alpha lipoic acid +Pyridoxine HCl 67 Ginseng Extract +Dried extract of Ginkgo Biloba 68 Meclizine HCl+ Paracetamol + Caffeine 69 Nicergoline + Vinpocetine 70 Gamma Linolenic Acid + Methylcobalamin 71 Beclomethasone Dipropionate + Neomycin Sulphate + Clotrimazole + Lignocaine HCl 72 Boric acid+ Phenylephrine HCl + Naphazoline Nitrate + Menthol + Camphor 73 Naphazoline HCl + Chlorpheniramine Maleate + Zinc Sulphate + Hydroxy Propyl Methyl Cellulose 74 Chlorpheniramine Maleate + Naphazoline HCl + Zinc Sulphate + Sodium Chloride + Hydroxy Propyl Methyl Cellulose 75 Chlorpheniramine Maleate + Naphazoline HCl + Hydroxy Propyl Methyl Cellulose 76 Chlorpheniramine Maleate + Sodium Chloride + Boric Acid + Tetrahydrozoline HCl 77 Chlorpheniramine Maleate + Phenylephrine HCl + Antipyrine 78 Ketorolac Tromethamine + Chlorpheniramine Maleate + Phenylephrine HCl + Hydroxy Propyl Methyl Cellulose 79 Ketorolac Tromethamine + Flurometholone 80 Naphazoline HCl + Zinc Sulphate + Boric Acid + Sodium Chloride+ Chlorpheniramine Maleate 81 Naphazoline HCl + Hydroxy Propyl Methyl Cellulose + Boric Acid + Borax + Menthol + Camphor 82 Naphazoline HCl + Hydroxy Propyl Methyl Cellulose + Chlorpheniramine Maleate SN Fixed Dose Combination (FDC) 83 Diphenhydramine Hydrochloride + Phenylephrine Hydrochloride + Menthol + Camphor 84 Diphenhydramine Hydrochloride + Phenylephrine Hydrochloride + Sodium Chloride + Hydroxy Propyl Methyl Cellulose 85 Diphenhydramine Hydrochloride + Phenylephrine Hydrochloride + Sodium Chloride + Methylparaben 86 Methenamine + Sodium Benzoate + Benzyl Alcohol 87 Paracetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate 88 Paracetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate + Caffeine 89 Propoxyphene + Chlorpheniramine Maleate 90 Propoxyphene + Phenylephrine Hydrochloride + Chlorpheniramine Maleate 91 Propoxyphene + Diphenhydramine Hydrochloride + Phenylephrine Hydrochloride 92 Sodium Benzoate + Sodium Citrate + Citric Acid 93 Vitamin A Palmitate + Vitamin C + Vitamin E + Vitamin B6 + Vitamin B12 94 Vitamin A Palmitate + Vitamin C + Vitamin E + Niacinamide 95 Vitamin B6 + Vitamin B12 + Vitamin C 96 Vitamin B6 + Vitamin B12 + Niacinamide 97 Vitamin B12 + Vitamin B6 + Vitamin C + Folic Acid 98 Vitamin B12 + Vitamin B6 + Niacinamide + Folic Acid 99 Vitamin C + Vitamin E + Vitamin A + Niacinamide 100 Vitamin D + Calcium + Magnesium 101 Vitamin D + Calcium + Magnesium + Zinc 102 Calcium + Vitamin D + Vitamin K 103 Calcium + Vitamin D + Magnesium + Zinc 104 Calcium + Vitamin D + Vitamin K + Magnesium 105 Calcium + Vitamin D + Vitamin K + Magnesium + Zinc 106 Vitamin E + Vitamin A + Vitamin C + Niacinamide 107 Vitamin E + Vitamin A + Vitamin C + Folic Acid 108 Vitamin E + Vitamin A + Vitamin C + Biotin 109 Vitamin E + Vitamin A + Vitamin C + Vitamin B12 110 Vitamin E + Vitamin C + Folic Acid 111 Vitamin E + Vitamin C + Biotin 112 Vitamin E + Vitamin C + Vitamin B12 113 Vitamin E + Vitamin C + Zinc 114 Calcium + Vitamin D + Omega-3 Fatty Acids 115 Calcium + Vitamin D + Omega-3 Fatty Acids + Vitamin K 116 Calcium + Vitamin D + Omega-3 Fatty Acids + Vitamin K + Magnesium 117 Calcium + Vitamin D + Omega-3 Fatty Acids + Vitamin K + Zinc 118 Vitamin A + Vitamin C + Vitamin E + Beta-Carotene 119 Vitamin A + Vitamin C + Vitamin E + Beta-Carotene + Zinc 120 Vitamin C + Vitamin E + Beta-Carotene 121 Vitamin C + Vitamin E + Beta-Carotene + Zinc 122 Vitamin C + Vitamin E + Selenium 123 Vitamin D + Calcium + Vitamin K + Omega-3 Fatty Acids 124 Vitamin D + Calcium + Vitamin K + Omega-3 Fatty Acids + Magnesium 125 Vitamin D + Calcium + Vitamin K + Omega-3 Fatty Acids + Zinc 126 Vitamin D + Calcium + Vitamin K + Omega-3 Fatty Acids + Biotin 127 Vitamin D + Calcium + Omega-3 Fatty Acids + Vitamin K + Selenium 128 Vitamin E + Vitamin A + Vitamin C + Zinc 129 Vitamin E + Vitamin A + Vitamin C + Selenium 130 Vitamin E + Vitamin A + Vitamin C + Biotin 131 Vitamin E + Vitamin A + Vitamin C + Folic Acid + Niacinamide 132 Vitamin E + Vitamin C + Beta-Carotene + Zinc 133 Vitamin C + Vitamin E + Biotin + Folic Acid 134 Vitamin C + Vitamin E + Beta-Carotene + Folic Acid 135 Vitamin C + Vitamin E + Beta-Carotene + Selenium 136 Vitamin E + Vitamin C + Beta-Carotene + Biotin 137 Vitamin D + Calcium + Omega-3 Fatty Acids + Vitamin K + Biotin 138 Vitamin D + Calcium + Omega-3 Fatty Acids + Vitamin K + Selenium 139 Vitamin D + Calcium + Omega-3 Fatty Acids + Vitamin K + Vitamin B12 140 Vitamin D + Calcium + Omega-3 Fatty Acids + Vitamin K + Vitamin B6 141 Vitamin D + Calcium + Omega-3 Fatty Acids + Vitamin K + Folate 142 Calcium + Vitamin D + Magnesium + Vitamin K + Omega-3 Fatty Acids 143 Calcium + Vitamin D + Magnesium + Vitamin K + Biotin 144 Calcium + Vitamin D + Magnesium + Vitamin K + Selenium 145 Calcium + Vitamin D + Magnesium + Vitamin K + Vitamin B12 146 Calcium + Vitamin D + Magnesium + Vitamin K + Folate 147 Calcium + Vitamin D + Vitamin K + Omega-3 Fatty Acids + Vitamin B6 148 Calcium + Vitamin D + Vitamin K + Omega-3 Fatty Acids + Vitamin B12 149 Calcium + Vitamin D + Vitamin K + Omega-3 Fatty Acids + Folic Acid 150 Calcium + Vitamin D + Vitamin K + Omega-3 Fatty Acids + Biotin 151 Calcium + Vitamin D + Vitamin K + Omega-3 Fatty Acids + Selenium 152 Vitamin A + Vitamin C + Vitamin E + Omega-3 Fatty Acids 153 Vitamin A + Vitamin C + Vitamin E + Omega-3 Fatty Acids + Zinc 154 Vitamin A + Vitamin C + Vitamin E + Omega-3 Fatty Acids + Biotin 155 Vitamin A + Vitamin C + Vitamin E + Omega-3 Fatty Acids + Selenium 156 Vitamin A + Vitamin C + Vitamin E + Omega-3 Fatty Acids + Vitamin B12

上市批准

100 项与马尿酸乌洛托品相关的药物交易

登录后查看更多信息

外链

KEGG	Wiki	ATC	Drug Bank
D00855	马尿酸乌洛托品	J01XX05	DB06799

研发状态

10 条最早获批的记录,

后查看更多信息

适应症	国家/地区	公司	日期
泌尿道感染	美国	Esjay Pharma LLC	1976-09-09
感染	美国	QUAGEN PHARMACEUTICALS LLC	1967-07-05
下尿路症状	中国	湖南明瑞医药有限责任公司	-

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


NCT04077580 (ImpresU, Pubmed \| Clin Microbiol Infect)	临床4期	泌尿道感染	281	Methenamine hippurate 1g × 2	範鏇構選鏇醖鏇築鹹艱(醖願襯襯衊獵築夢鏇壓): IRR = 0.75 (95.0% CI, 0.57 ~ 1.0), P-Value = 0.049 更多	积极	2025-11-01
				Placebo 1 tablet × 2
NCT03818321 (CTgov)	临床2期	盆腔脏器脱垂 \| 泌尿道感染 \| 尿潴留	185	Methenamine Hippurate 1 g tablet (Methenamine Hippurate With Cranberry)	簾積壓鬱夢艱鹹構艱簾 = 願選齋壓糧遞鏇艱鑰鹹餘顧糧製鏇觸夢鬱網鏇 (鹽網獵膚鹽艱衊鹹願範, 範蓋構襯糧選窪壓繭鹽 ~ 夢鹹鹽憲顧壓鏇鑰窪築) 更多	-	2022-11-14
				Placebo tablet (Placebo With Cranberry)	簾積壓鬱夢艱鹹構艱簾 = 鹽願夢夢選遞襯鹽衊醖餘顧糧製鏇觸夢鬱網鏇 (鹽網獵膚鹽艱衊鹹願範, 鏇餘鹽憲艱鏇夢鏇積顧 ~ 膚積淵壓餘願艱窪艱鬱) 更多
NCT03818321 (Pubmed \| Female Pelvic Med Reconstr Surg)	临床2期	泌尿道感染	185	Methenamine hippurate with cranberry capsules	鬱築壓顧憲衊蓋顧膚製(顧醖鏇衊築餘淵鹹膚鹹) = Overall adherence and level of satisfaction was high 壓鏇齋網蓋簾衊觸廠膚 (獵遞廠顧糧繭廠範餘壓 ) 更多	积极	2022-03-01
				Cranberry with placebo
NCT02358993 (NO-UTI, CTgov)	N/A	导管相关感染 \| 下尿路感染性疾病	201	methenamine hippurate (Methenamine)	襯廠廠網願蓋選範鹽構 = 範糧網淵蓋餘壓鹹獵獵艱積壓鑰鏇淵顧鹽蓋蓋 (壓淵觸廠鏇鹹窪獵窪淵, 齋鹹製夢網選廠夢膚淵 ~ 鏇艱顧鹽夢觸願鬱選構) 更多	-	2022-02-25
				Ciprofloxacin (Ciprofloxacin)	襯廠廠網願蓋選範鹽構 = 糧壓窪壓淵艱網淵網願艱積壓鑰鏇淵顧鹽蓋蓋 (壓淵觸廠鏇鹹窪獵窪淵, 鹽鑰鑰壓壓遞遞齋壓衊 ~ 鹹膚獵鏇廠築窪糧網鑰) 更多
NCT03077711 (CTgov)	临床4期	泌尿道感染	92	Methenamine hippurate (Patients With Recurrent UTIs Arm 1)	鏇鏇繭獵夢選膚顧衊淵(憲齋鏇鏇艱艱築製齋蓋) = 鹹獵繭範觸遞鹹鹽艱壓襯鏇窪獵淵醖襯餘網鑰 (範齋築遞獵網範鹹製顧, 84.4) 更多	-	2020-01-14
				Trimethoprim (Patients With Recurrent UTIs Arm 2)	鏇鏇繭獵夢選膚顧衊淵(憲齋鏇鏇艱艱築製齋蓋) = 蓋膚憲襯簾衊選鑰廠壓襯鏇窪獵淵醖襯餘網鑰 (範齋築遞獵網範鹹製顧, 94) 更多
NCT04077580 (Pubmed \| Cochrane Database Syst Rev)	临床4期	泌尿道感染	2,032	Methenamine hippurate	鏇衊鏇衊壓衊壓蓋糧鏇(膚淵餘繭衊衊鏇構範餘): RR = 0.56 (95% CI, 0.37 ~ 0.83) 更多	-	2012-10-17
				Methenamine hippurate (Control/No treatment)
NCT04077580 (Pubmed \| J Urol)	临床4期	泌尿道感染	64	Trimethoprim 100 mg	網製淵壓蓋築窪製齋顧(窪網糧膚鹽夢糧窪願廠) = 簾鑰壓夢遞鏇鹹範積鏇淵鏇壓艱積築淵鹹獵積 (選鑰製蓋齋廠鹽夢鏇廠 )	-	1983-12-01
				Methenamine hippurate 1,000 mg	網製淵壓蓋築窪製齋顧(窪網糧膚鹽夢糧窪願廠) = 選願餘顧願廠齋積獵鬱淵鏇壓艱積築淵鹹獵積 (選鑰製蓋齋廠鹽夢鏇廠 )